Filing Details
- Accession Number:
- 0001127602-20-022089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-24 16:24:54
- Reporting Period:
- 2020-07-23
- Accepted Time:
- 2020-07-24 16:24:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1731734 | Eric Benjamin | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Svp, Innovation And Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-23 | 6,520 | $210.00 | 8,704 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-07-23 | 1,396 | $30.02 | 10,100 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-23 | 6,996 | $29.26 | 17,096 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-23 | 8,392 | $210.00 | 8,704 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-07-23 | 1,396 | $0.00 | 1,396 | $30.02 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-07-23 | 6,996 | $0.00 | 6,996 | $29.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-07-01 | No | 4 | M | Direct | |
0 | 2026-02-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
- Includes 107 shares acquired under the Insulet Corporation Stock Purchase Plan on May 29, 2020.
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
- This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.